Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) EPS (Basic): 2017-2024

Historic EPS (Basic) for Tonix Pharmaceuticals Holding (TNXP) over the last 8 years, with Dec 2024 value amounting to -$176.60.

  • Tonix Pharmaceuticals Holding's EPS (Basic) rose 84.17% to -$3.59 in Q3 2025 from the same period last year, while for Sep 2025 it was $279.28, marking a year-over-year increase of 101.64%. This contributed to the annual value of -$176.60 for FY2024, which is 98.80% up from last year.
  • Latest data reveals that Tonix Pharmaceuticals Holding reported EPS (Basic) of -$176.60 as of FY2024, which was up 98.80% from -$14,720 recorded in FY2023.
  • Tonix Pharmaceuticals Holding's 5-year EPS (Basic) high stood at -$0.55 for FY2020, and its period low was -$14,720 during FY2023.
  • In the last 3 years, Tonix Pharmaceuticals Holding's EPS (Basic) had a median value of -$176.60 in 2024 and averaged -$4,972.
  • As far as peak fluctuations go, Tonix Pharmaceuticals Holding's EPS (Basic) plummeted by 73,464.47% in 2023, and later surged by 98.80% in 2024.
  • Tonix Pharmaceuticals Holding's EPS (Basic) (Yearly) stood at -$0.55 in 2020, then slumped by 1,372.73% to -$8.10 in 2021, then plummeted by 147.04% to -$20.01 in 2022, then tumbled by 73,464.47% to -$14,720 in 2023, then spiked by 98.80% to -$176.60 in 2024.